UNITED-GUARDIAN SIGNS CONTRACT WITH BAKER NORTON PHARMACEUTICALS INC.
HAUPPAUGE, N.Y., Nov. 17 ~PRNewswire~ -- United-Guardian, Inc. (AMEX: UG) announced today that it has appointed Baker Norton Pharmaceuticals Inc. as the exclusive distributor of Lubraseptic Jelly in the United States, Canada, Great Britain and Ireland. United- Guardian will supply Baker Norton Pharmaceuticals with its requirements of the products. Lubraseptic is not only an anesthetic but an antibacterial as well. As such, it is much more cost effective than the other anesthetic jellies. At a time when reducing medical costs is so important, the effectiveness of the product, combined with such a cost advantage, can be very advantageous. United-Guardian, which has marketed Lubraseptic as a medical anesthetic jelly for many years, expects that this agreement with Baker Norton Pharmaceuticals will increase sales of the product significantly in the first full year. United-Guardian is a manufacturer of pharmaceuticals, medical devices and healthcare products. Baker Norton Pharmaceuticals is a wholly owned subsidiary of Ivax Corp. (AMEX: IVX). -0- 11~17~92 ~CONTACT: United-Guardian, Inc. public relations, 516-273-0900~ (UG IVX)
CO: United-Guardian, Inc.; Ivax Corp. ST: New York IN: MTC SU: CON
SM-PS -- NY012 -- 1680 11~17~92 08:46 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 17, 1992|
|Previous Article:||BRITISH AIRWAYS MAINTAINS PROFIT MOMENTUM $199 MILLION NET PROFIT IN SECOND QUARTER,|
|Next Article:||U.S. HEALTHCARE ANNOUNCES 39 PERCENT INCREASE IN CASH DIVIDEND|